Jessica Gorham, APRN
Family · Westbrook, MENPI 1164018834
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,885 of the $2,116 with a category attached, or 89.1%. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $977, more than ten times the $49 reported in 2021. Among family clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $31.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$285
- AstraZeneca$276
- Pharmacosmos Therapeutics Inc.$233
- AbbVie$177
- Pharmacyclics LLC, An Abbvie Company$173
- Gilead$171
- plus $802 from 17 others
What the payments were for
- Food & beverage$1,88589%
- Education$23211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $285 |
| AstraZeneca | 7 | $276 |
| Pharmacosmos Therapeutics Inc. | 2 | $233 |
| AbbVie | 8 | $177 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $173 |
| Gilead | 3 | $171 |
| Astellas Pharma Global Development | 1 | $119 |
| Johnson & Johnson | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $88 |
| Amgen | 3 | $66 |
| Pfizer | 3 | $54 |
| Bristol Myers Squibb | 3 | $53 |
| Incyte Corporation | 2 | $50 |
| Exelixis Inc. | 2 | $45 |
| Array Biopharma Inc | 2 | $38 |
| Merck | 2 | $38 |
| Genentech USA, Inc. | 1 | $28 |
| Novartis | 1 | $23 |
| EMD Serono, Inc. | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monoferric$196
- Trodelvy$120
- PADCEV$119
- Enhertu$115
How this compares
$2,116 in reported general payments places this provider in the 90th percentile of 545 family providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 11 | $2,396 |
| Oxycodone Hcl | 49 | $831 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $593 |
| Ondansetron OdtOndansetron | 32 | $534 |
| Hydromorphone Hcl | 24 | $358 |
| Prochlorperazine Maleate | 36 | $335 |
| Anastrozole | 13 | $308 |
| Potassium Chloride | 15 | $152 |
| Ondansetron Hcl | 13 | $60 |
| Levofloxacin | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other family in Westbrook
- Sarah BoucherWestbrook$3K
- Elisabeth RobinsonWestbrook$2K
- Dixie KnollWestbrook$2K
- Jenna PaladinoWestbrook$1K
- Mia RapollaFalmouth$193K
- Patti DupreyKennebunk$35K
- Amanda WilliamsPortland$8K
- Jamie PiacentiniScarborough$6K
- Rosemary PainePortland$6K
- Brea SwihartAugusta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.